Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2026-01-17 @ 11:22 AM
Study NCT ID:
NCT02858193
Status:
COMPLETED
Last Update Posted:
2024-11-18
First Post:
2016-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-04
Start Date Type:
ACTUAL
Primary Completion Date:
2016-07-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-29
First Submit QC Date:
None
Study First Post Date:
2016-08-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-02-19
Results First Submit QC Date:
None
Results First Post Date:
2024-11-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-12
Last Update Post Date:
2024-11-18
Last Update Post Date Type:
ACTUAL